These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 737848)

  • 21. Practical aspects of internal quality assurance.
    Uldall A
    Ann Ist Super Sanita; 1991; 27(3):411-7. PubMed ID: 1809060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An interlaboratory evaluation of the IFCC method for aspartate aminotransferase with use of purified enzyme materials.
    Sampson EJ; Whitner VS; Burtis CA; McKneally SS; Fast DM; Bayse DD
    Clin Chem; 1980 Jul; 26(8):1156-64. PubMed ID: 7389087
    [No Abstract]   [Full Text] [Related]  

  • 23. Creation of the necessary analytical quality for generating and using reference intervals.
    Klein G; Junge W
    Clin Chem Lab Med; 2004; 42(7):851-7. PubMed ID: 15327022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sample size and rejection limits for detecting reagent lot variability: analysis of the applicability of the Clinical and Laboratory Standards Institute (CLSI) EP26-A protocol to real-world clinical chemistry data.
    Kim S; Chang J; Kim SK; Park S; Huh J; Jeong TD
    Clin Chem Lab Med; 2020 Jul; 59(1):127-138. PubMed ID: 32628625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential applications and pitfalls of dry reagent tests. An evaluation of the Ames Seralyzer.
    Clark PM; Broughton PM
    Ann Clin Biochem; 1983 Jul; 20 (Pt 4)():208-12. PubMed ID: 6614818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re.:Correction to the IFCC primary reference method for the measurement of catalytic activity concentration of enzymes at 37 degrees C - Part 2:reference procedure for the measurement of creatine kinase.
    Wood WG; Kramer U
    Clin Chem Lab Med; 2004 Mar; 42(3):353. PubMed ID: 15675027
    [No Abstract]   [Full Text] [Related]  

  • 27. Revised recommendation (1983) on evaluation of diagnostic kits. Part 1. Recommendations for specifications on labelling of clinical laboratory materials. International Federation of Clinical Chemistry.
    Logan JE
    Clin Chim Acta; 1984 Mar; 137(3):371F-379F. PubMed ID: 6697538
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunoassay external quality assessment schemes in France.
    Cohen R; Bizollon CA
    Ann Ist Super Sanita; 1991; 27(3):503-10. PubMed ID: 1809072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progress report on a national quality-control survey of triiodothyronine and thyroxin assay.
    Zucchelli GC; Pilo A; Chiesa MR; Piro MA
    Clin Chem; 1984 Mar; 30(3):395-8. PubMed ID: 6697485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. User modification of commercial immunoassay kits.
    Boeckx RL
    Clin Chem; 1992 Aug; 38(8 Pt 1):1402-3. PubMed ID: 1643705
    [No Abstract]   [Full Text] [Related]  

  • 31. Reference methods as a basis for accurate measuring systems.
    Büttner J
    Eur J Clin Chem Clin Biochem; 1991 Apr; 29(4):223-35. PubMed ID: 1868127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guidelines for description of immunoassay kits.
    Aakvaag A; Leskinen E; Lindstedt G; Möller J; Nyberg A; Weber T
    Scand J Clin Lab Invest; 1990 Feb; 50(1):95-8. PubMed ID: 2315649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The accuracy of laboratory measurements in clinical chemistry: a study of 11 routine chemistry analytes in the College of American Pathologists Chemistry Survey with fresh frozen serum, definitive methods, and reference methods.
    Ross JW; Miller WG; Myers GL; Praestgaard J
    Arch Pathol Lab Med; 1998 Jul; 122(7):587-608. PubMed ID: 9674541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality control and standardization of tumour marker tests.
    van Dalen A
    Tumour Biol; 1993; 14(2):131-5. PubMed ID: 8327837
    [No Abstract]   [Full Text] [Related]  

  • 35. Assessment of package inserts for diagnostic kits.
    Secchiero S; Sciacovelli L; Bonvicini P; Zaninotto M; Plebani M
    Clin Chem Lab Med; 1999 Jun; 37(6):663-5. PubMed ID: 10475075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metrological traceability of values for catalytic concentration of enzymes assigned to a calibration material.
    Canalias F; Camprubí S; Sánchez M; Gella FJ
    Clin Chem Lab Med; 2006; 44(3):333-9. PubMed ID: 16519608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economy and quality assessment of home made clinical chemistry reagents.
    Zafar MN; Syed S
    J Pak Med Assoc; 1992 Apr; 42(4):95-7. PubMed ID: 1597926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A pilot study on the quality management system of in-vitro diagnostic reagents].
    Liu X; Huang JH; Xu FL; Wang Z; Gu WK
    Zhongguo Yi Liao Qi Xie Za Zhi; 2006 May; 30(3):199-205. PubMed ID: 16929780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enzyme reference materials: their place in diagnostic enzymology.
    Moss DW
    Clin Chim Acta; 1994 Feb; 225(1):S5-11. PubMed ID: 8033351
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of urea reagent kits using the Centers for Disease Control and Prevention reference measurement procedures.
    Qiao R; Zhang Y; Zhang J
    Clin Lab; 2014; 60(10):1669-75. PubMed ID: 25651713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.